DRUG REGULATION IN iNDIA
India has the depressing record of having at least 5 major DEG (diethyline glucol)
poisoning events. When several children were severely ill in two hospitals in 2019, it
was found that a cough syrup they consumed tested positive of diethyline glycol, which
is a powerful industial solvent that is used in the manufacture of antifreeze, brake fluid etc.
Indian pharmaceutical companies quite often fail to test either the raw materials or the final
formulation before shipping to the market.
Many cases under investigation remain pending for a long time. Punishments are
often very small, due to lenient judges. Many times manufactured drugs fail quality testing.
India had its first ever Drug Act in 1940. Indian pharmaceutical industry has grown
exponentially during the twentieth century. Still, India's regulatory infrastructure has
evolved at a snail's pace. Only a few states liike Tamil Nadu and Gujarat appear to have
well-equipped drug-testing laboratories. Six central and regional laboratories were
equipped with good testing facilities.
Another revealing fact is that Indian doctors are aware that many formulations of
generic medicines manufactured in India do not have the expected therapeutic effect on
their patients. Pharmaceutical companies are also known to have improper influence on
drug regulation in India.
( Based on the book "The Truth Pill", written by
Dinesh Thakur and Prashant Reddy)
Comments
Post a Comment